C. Jiang, Xie, C., Lv, Y., Li, J., Krausz, K. W., Shi, J., Brocker, C. N., Desai, D., Amin, S. G., Bisson, W. H., Liu, Y., Gavrilova, O., Patterson, A. D., and Gonzalez, F. J.,
“Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction”,
Nature Communications, vol. 6, p. 10166, 2015.
] 